This study demonstrated that lncRNA LINC01194 accelerated HCC progression through the miR-655-3p/SMAD5 axis, showing that lncRNA LINC01194 served as a promising biomarker for patients with HCC. This evidence concerns the gene SMAD5 and hepatocellular carcinoma.